Evidence-based approach to active surveillance of prostate cancer.
Luke WitherspoonRodney H BreauLuke T LavalléePublished in: World journal of urology (2019)
Active surveillance is a good management option for some men with non-metastatic prostate cancer. In this review, we examine the evidence for several topics related to active surveillance. We examine: (1) which patients should be eligible for active surveillance, (2) what follow-up (monitoring) protocols should be used for men on surveillance, (3) what is the role of prostate magnetic resonance imaging (MRI) for men on surveillance, and (4) what is the prognosis for men who choose surveillance compared to radical treatment. In many instances, the evidence is evolving or lacking. In these situations, we highlight the limitations of the data.
Keyphrases
- prostate cancer
- magnetic resonance imaging
- public health
- middle aged
- radical prostatectomy
- end stage renal disease
- small cell lung cancer
- squamous cell carcinoma
- contrast enhanced
- computed tomography
- peritoneal dialysis
- magnetic resonance
- prognostic factors
- diffusion weighted imaging
- patient reported outcomes
- combination therapy